T5O.DE Gross Margin

The Gross Margin of bioXXmed AG (T5O.DE) is 100.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

T5O.DE Gross Margin - Historical Value

Date	Value
2022-12-31	100.00%
2021-12-31	100.00%
2020-12-31	-
2019-12-31	-
2018-12-31	-

T5O.DE Gross Margin - Peers Comparison

Ticker	Name	Value
IMTX	Immatics NV	7775.20%
MTPH.L	Midatech Pharma PLC	94.91%
AEGIR.ST	Aegirbio AB	47.83%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
BNTX	Biontech SE	84.90%
EGTX.ST	Egetis Therapeutics AB (publ)	74.84%
TRVX.OL	Targovax ASA	7775.20%
VVY.AS	Vivoryon Therapeutics NV	85.42%
AFMD	Affimed NV	83.70%
EVG.L	Evgen Pharma PLC	-1151.58%
GUARD.ST	Guard Therapeutics International AB (publ)	100.00%
LIDDS.ST	Lidds AB	-1102.81%
PUR.WA	Pure Biologics SA	-2709.47%
KURN.SW	Kuros Biosciences AG	109.30%
XINT.ST	Xintela AB	100.00%
ADOC.PA	Adocia SA	87.98%
FYB.DE	Formycon AG	20.25%
SENZA.ST	SenzaGen AB	66.89%
VSC.DE	4Sc AG	97.20%
ALPAT.PA	Plant Advanced Technologies PAT SA	128.03%
CNTG	Centogene NV	36.46%
CVAC	CureVac NV	80.23%
OXUR.BR	Oxurion NV	-1333.33%
RENE.L	ReNeuron Group PLC	100.00%
ABNX.PA	Abionyx Pharma SA	18.35%
ACTI.ST	Active Biotech AB publ	100.00%
ALPRE.PA	Predilife SA	97.25%
GV.PA	Genomic Vision SA	-165.01%
MVIR B.ST	Medivir AB	-1470.45%
ALHYG.PA	Hybrigenics SA	99.47%
ATORX.ST	Alligator Bioscience AB	-312.94%
HPHA.DE	Heidelberg Pharma AG	74.01%
ALNEV.PA	Neovacs SA	5.49%
BIO.DE	Biotest AG	30.82%
GNRO.PA	Geneuro SA	7775.20%
MOR.DE	MorphoSys AG	78.62%
PCIB.OL	PCI Biotech Holding ASA	100.00%